Patents by Inventor Marina Maria BOIDO

Marina Maria BOIDO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11407799
    Abstract: A compound comprising at least two components, a first component being the nLG3 or (h)nLG3 domain from the C-terminus of mouse or human agrin, and at least one second component, selected from proteins or an antagonistic antibody that inhibit ActR2B-induced signaling activity in the presence of myostatin, the components being linked by means of linking entities. Such compounds are effective treatments for neuromuscular diseases and problems.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: August 9, 2022
    Assignee: PHARMAFOX THERAPEUTICS AG
    Inventors: Jan Willem Vrijbloed, Marina Maria Boido, Olena Butenko, Roberta Schellino
  • Publication number: 20210253654
    Abstract: A compound comprising at least two components, a first component being the nLG3 or (h)nLG3 domain from the C-terminus of mouse or human agrin, and at least one second component, selected from proteins or an antagonistic antibody that inhibit ActR2B-induced signaling activity in the presence of myostatin, the components being linked by means of linking entities. Such compounds are effective treatments for neuromuscular diseases and problems.
    Type: Application
    Filed: November 28, 2017
    Publication date: August 19, 2021
    Inventors: Jan Willem VRIJBLOED, Marina Maria BOIDO, Olena BUTENKO, Roberta SCHELLINO